Forward Price-to-Revenue Multiple: IMAC Corp (BACK)

IMAC Corp (BACK) - corporate logo

Chronic capital shortages and the small scale of IMAC Holdings, Inc. (BACK) are weighing on share prices, causing the forward P/S ratio to exhibit high volatility. Meanwhile, the 9.80 level serves as a critical mark. Licenses and unique treatment protocols ensure business resilience, while the environmental strategy relies on a complete transition from paper documentation to digital records.

IMAC Holdings - BACK Forward Price to Sales (period 02/21/2024 - 04/05/2025)

IMAC Holdings, Inc. (BACK) - metric breakdowns and financial figures

- current price and projected stock value:
Stock Price IMAC Corp|BACK - Consensus Target
- company stock exchange capitalization indicators:
Market Valuation IMAC Holdings Inc|BACK - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share IMAC Holdings|BACK - Accounting Value of Company|Market Value to Book Value Ratio imacholdings.comm|BACK - Company Assets
- debt and solvency information:
Debt to Equity IMAC Holdings, Inc.|BACK - Long-Term Debt to Equity|Short-Term Debt to Capital IMAC Regeneration Centers|BACK - Company Aggregate Debt|Debts to Book Capitalization IMAC Regeneration Centers|BACK - Long-Term Debt Volume|Company Short-Term Debt IMAC Holdings|Quick Ratio imacholdings.comm
- financial results and valuation multiples details:
BACK - Annual Net Income|Expected Profit IMAC Holdings, Inc.|BACK - Business Payback Period|Projected Price to Earnings IMAC Holdings, Inc.|BACK - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple IMAC Regeneration Centers|BACK - Operating income before deduction of amortization|Earnings per share for the last twelve months IMAC Holdings|BACK - Earnings per share for the last 12 months|Quarterly EPS earnings growth imacholdings.comm|BACK - Net earnings per share growth this year|Expected earnings per share growth for next year IMAC Holdings, Inc.
- company sales and revenue statistics:
BACK - Company Gross Revenue|Projected Sales Volume IMAC Regeneration Centers|BACK - Price-to-Revenue Ratio|Forward P/S Multiple IMAC Holdings
Fundamental company valuation:IMAC Corp BACK
Original product of IMAC Corp

The forward multiple compares current market capitalization with expected sales volume, measuring the market premium for future revenue growth and business scaling efficiency. The price action of the forward P/S metric reflects how investors value the potential of the diversified rehabilitation center network of IMAC Holdings, Inc. (BACK), linking the stock price to the expansion of medical services ranging from orthopedics to neurosurgery.

Analysis of competing companies

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Forward P/S Multiple PNTG|Market Cap to Expected Sales Ratio Organogenesis Holdings|Forward P/S Multiple NUTX (nutexhealth.com)|Auna SA (AUNA) - Market Cap to Future Revenue Ratio|SBC: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Jeuveau EOLS|CYH (Community Health Systems Inc) - Forward Price-to-Revenue Multiple|SKIN: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple MDWD|BTMD: Forward Price to Sales|Price-to-Projected Revenue Ratio The Joint Corporation (JYNT)|Forward P/S Multiple DocGo Inc (DCGO)|Forward Price to Sales P3 Health Partners, Inc.|Market Cap to Expected Sales Ratio gaintherapeutics.com (GANX)|EUDA: Forward Price-to-Revenue Multiple|BMGL: Price-to-Projected Revenue Ratio|collplant.com (CLGN) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Cuprina Holdings|CCM (concordmedical.com) - Forward P/S Multiple|Forward P/S Multiple ASHS|Price-to-Projected Revenue Ratio MEDIROM (MRM)|ALBT - Market Cap to Future Revenue Ratio|DIH Holding US, Inc. - Forward Price-to-Revenue Multiple|Projected Price to Revenue Carmell Therapeutics Corporation|NewGenIvf Corp - Forward P/S Multiple|ATI Physical Therapy, Inc. - Price to Expected Revenue Ratio|CMAX: Forward P/S Multiple|Market Cap to Projected Revenue KDLY|Forward Price-to-Revenue Multiple MODV|Market Cap to Future Revenue Ratio Novo Integrated Sciences Inc NVOS|Forward P/S Multiple SSY